Stephen Oroszlan

1.8k total citations
28 papers, 1.6k citations indexed

About

Stephen Oroszlan is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Stephen Oroszlan has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in Stephen Oroszlan's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and T-cell and Retrovirus Studies (8 papers). Stephen Oroszlan is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and T-cell and Retrovirus Studies (8 papers). Stephen Oroszlan collaborates with scholars based in United States, Hungary and Switzerland. Stephen Oroszlan's co-authors include Terry D. Copeland, Ralph Snyderman, George J. Cianciolo, Dolph L. Hatfield, Bruce A. Shapiro, Jacob V. Maizel, Edward M. Scolnick, Douglas R. Lowy, Thomas Y. Shih and Ronald Ellis and has published in prestigious journals such as Science, Biochemistry and Analytical Biochemistry.

In The Last Decade

Stephen Oroszlan

28 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Oroszlan United States 19 828 404 374 300 285 28 1.6k
S Oroszlan United States 19 941 1.1× 461 1.1× 498 1.3× 225 0.8× 348 1.2× 28 2.0k
Joseph P. Davide United States 22 1.3k 1.5× 265 0.7× 508 1.4× 461 1.5× 392 1.4× 37 2.1k
Alexander Zdanov United States 27 1.1k 1.3× 775 1.9× 199 0.5× 414 1.4× 233 0.8× 44 2.3k
Gary W. Smythers United States 18 845 1.0× 248 0.6× 324 0.9× 111 0.4× 173 0.6× 33 1.4k
Alan M. Schultz United States 18 849 1.0× 360 0.9× 476 1.3× 110 0.4× 168 0.6× 27 1.5k
R. Crowther United States 18 927 1.1× 491 1.2× 200 0.5× 165 0.6× 112 0.4× 23 1.8k
Hiroo Hoshino Japan 29 746 0.9× 868 2.1× 647 1.7× 373 1.2× 458 1.6× 99 2.3k
Patrick Kanda United States 22 915 1.1× 457 1.1× 576 1.5× 92 0.3× 241 0.8× 46 1.7k
Ian Bathurst United States 25 820 1.0× 443 1.1× 291 0.8× 158 0.5× 302 1.1× 65 2.1k
Herbert Jaksche Austria 14 976 1.2× 309 0.8× 353 0.9× 116 0.4× 178 0.6× 17 1.4k

Countries citing papers authored by Stephen Oroszlan

Since Specialization
Citations

This map shows the geographic impact of Stephen Oroszlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Oroszlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Oroszlan more than expected).

Fields of papers citing papers by Stephen Oroszlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Oroszlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Oroszlan. The network helps show where Stephen Oroszlan may publish in the future.

Co-authorship network of co-authors of Stephen Oroszlan

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Oroszlan. A scholar is included among the top collaborators of Stephen Oroszlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Oroszlan. Stephen Oroszlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xueming, Bradley A. Carlson, Tobias Grimm, et al.. (2002). Rhesus Monkey Simian Immunodeficiency Virus Infection as a Model for Assessing the Role of Selenium in AIDS. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(5). 453–463. 19 indexed citations
2.
Zahuczky, Gábor, Péter Boross, Péter Bagossi, et al.. (2000). Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1478(1). 1–8. 12 indexed citations
3.
Boross, Péter, et al.. (1999). Effect of substrate residues on the P2′ preference of retroviral proteinases. European Journal of Biochemistry. 264(3). 921–929. 32 indexed citations
4.
Carlson, Bradley A., So Yeon Kwon, Mario Chamorro, et al.. (1999). Transfer RNA Modification Status Influences Retroviral Ribosomal Frameshifting. Virology. 255(1). 2–8. 61 indexed citations
5.
Cushman, Mark, et al.. (1991). Development of methodology for the synthesis of stereochemically pure Phe.psi.[CH2N]Pro linkages in HIV protease inhibitors. The Journal of Organic Chemistry. 56(13). 4161–4167. 23 indexed citations
6.
Hatfield, Dolph L. & Stephen Oroszlan. (1990). The where, what and how of ribosomal frameshifting in retroviral protein synthesis. Trends in Biochemical Sciences. 15(5). 186–190. 65 indexed citations
7.
Cushman, Mark, et al.. (1990). An Approach to the Synthesis of HIV Protease Inhibitors. Annals of the New York Academy of Sciences. 616(1). 503–507. 2 indexed citations
8.
Wondrak, Ewald M., et al.. (1990). A solid phase assay for the protease of human immunodeficiency virus. Analytical Biochemistry. 188(1). 82–85. 15 indexed citations
9.
Copeland, Terry D., Ewald M. Wondrak, József Tőzsér, Michael M. Roberts, & Stephen Oroszlan. (1990). Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor. Biochemical and Biophysical Research Communications. 169(1). 310–314. 65 indexed citations
10.
Nashed, Nashaat T., John M. Louis, Jane M. Sayer, et al.. (1989). Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV. Biochemical and Biophysical Research Communications. 163(2). 1079–1085. 46 indexed citations
11.
Copeland, Terry D., et al.. (1989). Synthetic non-peptide inhibitors of HIV protease. Biochemical and Biophysical Research Communications. 163(2). 980–987. 31 indexed citations
12.
Kung, Hsiang‐Fu, et al.. (1989). Phosphorylation of human interleukin-2 (IL-2). Molecular and Cellular Biochemistry. 89(1). 29–35. 6 indexed citations
13.
DeVico, Anthony L., Terry D. Copeland, Fulvia Veronese, et al.. (1989). Purification and Partial Characterization of Human Immunodeficiency Virus Type 2 Reverse Transcriptase. AIDS Research and Human Retroviruses. 5(1). 51–60. 27 indexed citations
15.
Oroszlan, Stephen, et al.. (1988). Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virys protease. PubMed. 5(6). 109–115. 70 indexed citations
16.
Hatfield, Dolph L., Snorri S. Thorgeirsson, Terry D. Copeland, Stephen Oroszlan, & Michael Bustin. (1988). Immunopurification of the suppressor tRNA dependent rabbit .beta.-globin readthrough protein. Biochemistry. 27(4). 1179–1183. 13 indexed citations
17.
Rice, Nancy R., Terry D. Copeland, Stephanie L. Simek, Stephen Oroszlan, & Raymond V. Gilden. (1986). Detection and characterization of the protein encoded by the v-rel oncogene. Virology. 149(2). 217–229. 43 indexed citations
18.
Yoshinaka, Yoshiyuki & Stephen Oroszlan. (1985). Bovine leukemia virus post-envelope gene coded protein: Evidence for expression in natural infection. Biochemical and Biophysical Research Communications. 131(1). 347–354. 14 indexed citations
19.
Dhar, Ravi, Ronald Ellis, Thomas Y. Shih, et al.. (1982). Nucleotide Sequence of the p21 Transforming Protein of Harvey Murine Sarcoma Virus. Science. 217(4563). 934–936. 244 indexed citations
20.
Oroszlan, Stephen, et al.. (1980). Rapid stepwise solubilization and purification of type C retrovirus structural proteins by extraction with organic solvent. Analytical Biochemistry. 103(2). 331–336. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026